These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28776345)

  • 1. Influence of Daytime or Nighttime Dosing with Solifenacin for Overactive Bladder with Nocturia: Impact on Nocturia and Sleep Quality.
    Kwon T; Oh TH; Choi S; Cho WY; Min K; Lee JZ; Moon KH
    J Korean Med Sci; 2017 Sep; 32(9):1491-1495. PubMed ID: 28776345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance.
    Takao T; Tsujimura A; Yamamoto K; Fukuhara S; Nakayama J; Matsuoka Y; Miyagawa Y; Nonomura N
    Urology; 2011 Sep; 78(3):648-52. PubMed ID: 21676440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).
    Yamaguchi O; Kakizaki H; Homma Y; Igawa Y; Takeda M; Nishizawa O; Gotoh M; Yoshida M; Yokoyama O; Seki N; Okitsu A; Hamada T; Kobayashi A; Kuroishi K
    BJU Int; 2015 Oct; 116(4):612-22. PubMed ID: 25639296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of combination therapy of tamsulosin and solifenacin for mild and moderate benign prostatic hyperplasia with overactive bladder].
    Gao ZW; Xin SY; Zhang JG; Ren XQ; Shang YF; Zhang W; Li HB; Xiao F; Shao CS
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):239-43. PubMed ID: 24738461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Two Different Drugs for Overactive Bladder, Solifenacin and Mirabegron: A Prospective Randomized Crossover Study.
    Inoue M; Yokoyama T
    Acta Med Okayama; 2019 Oct; 73(5):387-392. PubMed ID: 31649364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
    Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
    Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease.
    Zesiewicz TA; Evatt M; Vaughan CP; Jahan I; Singer C; Ordorica R; Salemi JL; Shaw JD; Sullivan KL;
    Parkinsonism Relat Disord; 2015 May; 21(5):514-20. PubMed ID: 25814050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of solifenacin therapy in patients with overactive bladder in the clinical setting: a prospective, multicenter, observational study.
    Kim TH; You HW; Park JH; Lee JG; Choo MS; Park WH; Lee JZ; Park CH; Na YG; Kwon DD; Lee KS
    Int J Clin Pract; 2016 Apr; 70(4):351-7. PubMed ID: 27028673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms.
    Liu M; Wang J; Yang Y; An R; Wen J; Guan Z; Zheng S; Wang D; Song B; Liao L; Guo H; Xiao J; Sun Y; Shen Z; Kong C; He D; Huang Y; Wang X; Zhang X; Li H; Huang J; Zhao X; Zeng P; Song X; Ye Z
    Chin Med J (Engl); 2014; 127(2):261-5. PubMed ID: 24438613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms.
    Lee HN; Lee KS; Kim JC; Chung BH; Kim CS; Lee JG; Kim DK; Park CH; Park JK; Hong SJ
    Int J Clin Pract; 2015 Apr; 69(4):444-53. PubMed ID: 25363606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
    Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
    Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of imidafenacin on nocturia and sleep disorder in patients with overactive bladder.
    Wada N; Watanabe M; Kita M; Matsumoto S; Osanai H; Yamaguchi S; Numata A; Fujisawa M; Saga Y; Hou K; Iuchi H; Niibori D; Kura T; Taniguchi A; Kunieda M; Nakata Y; Kakizaki H
    Urol Int; 2012; 89(2):215-21. PubMed ID: 22832092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overactive Bladder Symptom Scores responsiveness before and after anticholinergic treatment in women with overactive bladder: The pilot study.
    Bunyavejchevin S
    J Obstet Gynaecol Res; 2017 Jul; 43(7):1189-1193. PubMed ID: 28612999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
    Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
    Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome.
    Park J; Chun JY; Kim JH; Cheon SY; Song M; Choo MS; Lee KS; Oh SJ; Kim JC; Choi JB; Seo JT; Cho SY
    Int Urol Nephrol; 2015 Feb; 47(2):235-42. PubMed ID: 25503446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms.
    Brubaker L; FitzGerald MP
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Jul; 18(7):737-41. PubMed ID: 17131169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined solifenacin and aclatonium in preventing dry mouth in patients with overactive bladder.
    Park HK; Kim HG; Yang DY; Choi WS; Paick SH; Chung H; Yang SK
    Low Urin Tract Symptoms; 2019 Jan; 11(1):56-60. PubMed ID: 28967201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of solifenacin on the improvement of storage symptoms in the early period after photoselective vaporization of the prostate.
    Kim SJ; Bae WJ; Kim SW
    Investig Clin Urol; 2019 Nov; 60(6):480-487. PubMed ID: 31692851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD; Lucente V; Vapnek J; Smith N
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.